A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
Jan 11, 2024
0
10
Ethanol—the compound found in alcoholic beverages—interferes with the normal functioning of a long list of biological molecules, but how each of these interactions contributes to the behavioral effects of alcohol is not ...
Jan 9, 2024
0
1
Many physicians are unfamiliar with how the Food and Drug Administration's (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than ...
Jan 9, 2024
0
0
The U.S. Food and Drug Administration is currently investigating whether or not the cinnamon used in applesauce pouches that have been tied to high lead levels in children may have been deliberately tainted with the toxic ...
Dec 19, 2023
0
0
The golden road to pharmaceutical riches can quickly become a rocky wilderness trail. Chemical compounds that hit a target in the lab often fall short in human studies.
Dec 13, 2023
0
18
It's winter and many people are contending with the sniffles and coughs. For some, that means heading to the pharmacy to resupply on cold medications.
Dec 11, 2023
0
0
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer ...
Dec 11, 2023
0
0
Systemic lupus erythematosus (SLE) is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...
Dec 8, 2023
0
5
The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, which stands for clustered regularly interspaced short palindromic ...
Dec 8, 2023
0
4
A new Northwestern University study—led by Bernard Black of Northwestern's Pritzker School of Law and Kellogg School of Management—suggests that the U.S. could have saved many lives by authorizing a COVID-19 booster dose ...
Dec 5, 2023
0
2
